These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 24563491)

  • 1. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis.
    Desrosiers NA; Himes SK; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Clin Chem; 2014 Apr; 60(4):631-43. PubMed ID: 24563491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration.
    Schwope DM; Karschner EL; Gorelick DA; Huestis MA
    Clin Chem; 2011 Oct; 57(10):1406-14. PubMed ID: 21836075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis.
    Scheidweiler KB; Schwope DM; Karschner EL; Desrosiers NA; Gorelick DA; Huestis MA
    Clin Chem; 2013 Jul; 59(7):1108-17. PubMed ID: 23519966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users.
    Lee D; Bergamaschi MM; Milman G; Barnes AJ; Queiroz RH; Vandrey R; Huestis MA
    J Anal Toxicol; 2015 Oct; 39(8):580-7. PubMed ID: 26378131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
    Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
    Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.
    Scheidweiler KB; Newmeyer MN; Barnes AJ; Huestis MA
    J Chromatogr A; 2016 Jul; 1453():34-42. PubMed ID: 27236483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.
    Anizan S; Milman G; Desrosiers N; Barnes AJ; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2013 Oct; 405(26):8451-61. PubMed ID: 23954944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence.
    Milman G; Bergamaschi MM; Lee D; Mendu DR; Barnes AJ; Vandrey R; Huestis MA
    Ther Drug Monit; 2014 Apr; 36(2):218-24. PubMed ID: 24067260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis.
    Desrosiers NA; Lee D; Scheidweiler KB; Concheiro-Guisan M; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2014 Jan; 406(3):785-92. PubMed ID: 24292435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking.
    Lee D; Vandrey R; Mendu DR; Murray JA; Barnes AJ; Huestis MA
    Drug Test Anal; 2015 Jun; 7(6):494-501. PubMed ID: 25220020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.
    Schwope DM; Scheidweiler KB; Huestis MA
    Anal Bioanal Chem; 2011 Sep; 401(4):1273-83. PubMed ID: 21727996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?
    Hädener M; Martin Fabritius M; König S; Giroud C; Weinmann W
    Drug Test Anal; 2017 Jul; 9(7):1043-1051. PubMed ID: 27732768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid disposition in oral fluid after controlled smoked cannabis.
    Lee D; Schwope DM; Milman G; Barnes AJ; Gorelick DA; Huestis MA
    Clin Chem; 2012 Apr; 58(4):748-56. PubMed ID: 22273566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge.
    Lee D; Vandrey R; Mendu DR; Anizan S; Milman G; Murray JA; Barnes AJ; Huestis MA
    Clin Chem; 2013 Dec; 59(12):1770-9. PubMed ID: 23938457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.